高危阻塞性睡眠呼吸暂停患者持续气道正压通气的心血管获益:多试验分析
该事后汇总分析纳入三项随机试验共3549例患者,按OSA相关心率加速或低氧负荷定义高危OSA。
要点
- 高危OSA(心率反应>9.4 b.p.m.或低氧负荷>87.1% min/h)患者从CPAP治疗中获益更明显。
- 无过度嗜睡或无血压升高的高危OSA患者中,CPAP的获益差异更显著。
- 低危OSA患者中CPAP可能有害,需避免不加选择地治疗。
核心结论
- CPAP优先改善高危OSA患者的心血管结局,低危OSA中的伤害可能抵消该效应,为识别获益人群提供路径。
研究设计与样本
- 三项随机试验(RICCADSA、ISAACC、SAVE)的事后汇总分析,共3549例参与者,按高危OSA状态分层,采用Cox混合模型分析MACCE。
主要发现
- CPAP组16.6%、常规护理组16.3%达到MACCE终点。
- 高危OSA中CPAP获益的同时,低危OSA中观察到伤害。
关键数值与推荐
- 高危OSA定义为OSA呼吸事件后心率反应>9.4 b.p.m.(第三三分位)或氧饱和度低于基线的曲线下面积(低氧负荷)>87.1% min/h(第三三分位)。
- 无过度嗜睡定义为Epworth嗜睡评分<11分。
- 无血压升高定义为收缩压/舒张压<140/90 mmHg。
临床怎么用
- 对OSA患者应评估心率反应和低氧负荷以识别高危者,对此类患者CPAP可能带来心血管获益。
- 无过度嗜睡或无血压升高的高危OSA患者可能从CPAP治疗中获益更明显。
- 低危OSA患者使用CPAP可能有害,需谨慎选择治疗对象。
局限性
- 为事后分析,结果需前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Randomized trials of continuous positive airway pressure (CPAP) treatment for obstructive sleep apnoea (OSA) in patients with cardiovascular disease have not detected reduced risk of major adverse cardiovascular and cerebrovascular events (MACCEs). This study tested whether the cardiovascular benefit of CPAP occurs preferentially in high-risk OSA, characterized by greater OSA-related heart rate acceleration or hypoxaemia. METHODS: In a post hoc analysis of pooled Randomized Intervention with Continuous Positive Airway Pressure in Coronary Artery Disease and Obstructive Sleep Apnoea, Impact of Continuous Positive Airway Pressure on Patients with Acute Coronary Syndrome and Nonsleepy Obstructive Sleep Apnoea, and Sleep Apnoea Cardiovascular Endpoints Study randomized trials; outcomes were stratified by high-risk OSA status, defined by heart rate response following OSA respiratory events >9.4 b.p.m. (third tertile) or oxygen desaturation area under baseline (hypoxic burden) > 87.1% min/h (third tertile). Cox mixed models quantified the CPAP treatment effect on MACCE (including cardiovascular mortality, myocardial infarction, and stroke) within high-risk OSA and the difference vs low-risk status (primary test). Secondary analyses examined participants without excessive sleepiness (Epworth <11 points) or without increased blood pressure (systolic/diastolic <140/90 mmHg). RESULTS: In 3549 participants, 16.6% and 16.3% reached the MACCE endpoint with CPAP (n = 1778) and usual care (n = 1771), respectively. The CPAP treatment effect was greater in participants with vs without high-risk OSA [interaction hazard ratio (iHR) .69, 95% confidence interval (CI) .50-.95, Pinteraction = .024; Nhigh-risk = 1832]. The differential effect was stronger in those without excessive sleepiness (iHR .59, 95% CI .41-.84; Nhigh-risk = 1509), or without increased blood pressure (iHR .54, 95% CI .36-.81; Nhigh-risk = 1244). Continuous positive airway pressure benefits in high-risk OSA were observed alongside harm in low-risk OSA. CONCLUSIONS: Continuous positive airway pressure preferentially improves cardiovascular outcomes in high-risk OSA, while harm in low-risk OSA may counteract this effect. These findings provide a pathway to identify patients likely to benefit.
引用
- Azarbarzin, Vena, Esmaeili, et al. Cardiovascular benefit of continuous positive airway pressure according to high-risk obstructive sleep apnoea: a multi-trial analysis. Eur Heart J. 2026. PMID: 40794640. doi:10.1093/eurheartj/ehaf447
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。